CorMedix Inc.
CRMD
$6.10
-$0.20-3.18%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 14.89% | 70.82% | 113.22% | 97.75% | 139.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.63% | 40.85% | 36.45% | 51.62% | 86.11% |
| Operating Income | 182.56% | 68.59% | -29.62% | -51.62% | -86.77% |
| Income Before Tax | 191.26% | 71.50% | -25.53% | -50.10% | -79.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 191.26% | 71.50% | -25.53% | -36.90% | -79.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 191.26% | 71.50% | -25.53% | -36.90% | -79.73% |
| EBIT | 182.56% | 68.59% | -29.62% | -51.62% | -86.77% |
| EBITDA | 183.51% | 69.28% | -29.16% | -51.65% | -87.05% |
| EPS Basic | 185.14% | 72.61% | 1.17% | -4.96% | -31.11% |
| Normalized Basic EPS | 185.13% | 72.61% | 1.16% | -15.09% | -31.08% |
| EPS Diluted | 185.14% | 72.61% | 1.17% | -4.96% | -31.11% |
| Normalized Diluted EPS | 185.13% | 72.61% | 1.16% | -15.09% | -31.08% |
| Average Basic Shares Outstanding | 7.17% | 4.02% | 27.01% | 30.42% | 37.12% |
| Average Diluted Shares Outstanding | 7.17% | 4.02% | 27.01% | 30.42% | 37.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
